RE:RE:RE:RE:RVX - Managing PerceptionsHi Jkj.
Excellent point and great for Pat.
A few ideas.
- I think that repetition of the Feb webcast in bullet points may help - e.g. -2% point plaque reduction in low HDL high CVD patients, regression achieved in very short time period (6 weeks), increased HDL-P (the more accurate measure for the good cholesterol), no liver damage, AND significantly reduced MACE (hence a possibility of trial acceleration and movement to the market). There may be other bullet points but I can't remember them.
- Market potential of $14,000,000,000 in the USA alone and double that including expanded markets.
- The fact that Crestor will be losing it's patent protection and that rvx-208 can work with the generic statins.
- Reposting on venture capital websites.
- Posting on websites that may cater to those with CVD.
I'm sure others will have better ideas and the opportunity to spread the good news seems huge.
Keep the good news flowing. Those post hoc results are incredible and with very low p values (i.e. not just random chance).
Cheers
Toinv